Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away.
That’s the vision of the field of bioelectronic medicine — the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News(C&EN), the weekly news magazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.
Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.
The Latest on: Bioelectronics
via Google News
The Latest on: Bioelectronics
- BioElectronics Corporation Discusses Q2 Financialson August 30, 2021 at 7:00 am
FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) said today that it would ...
- BioElectronics Corporation Discusses Q2 Financialson August 30, 2021 at 5:03 am
Key facts from the Q2 financials many of which were found in the footnotes: The CEO again took no pay, and the Chairman invested additional cash into the Company. Two major lenders neither collected ...
- BioElectronics Corp.on August 27, 2021 at 8:58 am
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
- Diamond Electronics and Bioelectronics — Fundamentals to Applications IVon August 17, 2021 at 7:02 am
Symposium A, “Diamond Electronics and Bioelectronics—Fundamentals to Applications IV,” was held Nov. 29–Dec. 3 at the 2010 MRS Fall Meeting in Boston, Massachusetts, and resulted in this volume ...
- Flexible and Conductive Mesh for Implantable and Wearable Bioelectronicson August 13, 2021 at 4:59 pm
Study in Nature Nanotechnology: Highly conductive, stretchable and biocompatible Ag–Au core–sheath nanowire composite for wearable and implantable bioelectronics Conn Hastings received a PhD ...
- Next-Generation Graphene Bioelectronics for Targeting Severe Chronic Diseaseson August 11, 2021 at 12:23 pm
This expansion has recently spread to graphene bioelectronics. Bioelectronics target nerve signals which are altered or dysregulated in the body using minuscule devices that are implanted to modulate ...
- Bioelectronics Market Rapidly Develop, Top Manufacturers Forecast to 2027: F. Hoffmann-La Roche, Abbott laboratories, LifeSensors, Siemens Healthcareon August 10, 2021 at 3:21 am
F. Hoffmann-La Roche Ltd, Abbott laboratories, LifeSensors, Siemens Healthcare, Nova Biomedical Corporation and AgaMatrix. FREE | Request Sample is Available @ *The Sample only consist of Table of ...
- Bioelectronics get upgrade with novel approach to create more stable, electrically efficient deviceson August 9, 2021 at 10:55 am
Researchers at the University of Chicago have patented a new approach for developing carbon-based bioelectronic devices, which have a variety of applications in drug delivery, substance detection, and ...
via Bing News
